GREY:IPHAF - Post by User
Post by
ISAloser247on Aug 15, 2011 5:15pm
351 Views
Post# 18944597
FEBRUARY 2011, $4.5 million + $2.35 million...
FEBRUARY 2011, $4.5 million + $2.35 million... ....ISA received in license fee and first tranche purchase of shares.
"This transaction provides ALL stakeholders a real opportunity to realize the FULL VALUE of OUR
critical voclosporin asset" Dr. Robert Foster.
HEY BOBBY, HOW DOES THE GRANTING OF RECENT STOCK OPTIONS, PROVIDE FULL VALUE FOR ALL
STAKEHOLDERS? HONESTY! INTEGRITY!